Pharmaids Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE117D01018
NSEID:
BSEID: 524572

INR

50.87

1.17 (2.35%)

BSENSE

Dec 19

BSE+NSE Vol: 1.9 k

{
  "main_header": {
    "sid": 799751,
    "name": "Pharmaids Pharma",
    "stock_name": "Pharmaids Pharma",
    "full_name": "Pharmaids Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/pharmaids-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "50.87",
    "chg": 1.17,
    "chgp": "2.35%",
    "dir": 1,
    "prev_price": "49.70",
    "mcapval": "175.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524572,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE117D01018",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "1.9 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pharmaids-pharma-799751-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Pharmaids Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-pharmaids-pharma-fallingrising-3760498",
        "imagepath": "",
        "date": "2025-12-17 01:07:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Dynamics and Market Context</strong></p>\n<p>Pharmaids Pharma’s price dipped by 0.04% on 16-Dec, a relatively negligible change in absolute terms but indicative of a cautious market sentiment. Over the past week, the stock has declined by 1.56%, contrasting with the Sensex’s modest gain of 0.02% during the same period. This short-term underperformance suggests some immediate pressures on the stock, possibly linked to reduced investor enthusiasm or profit-taking activities.</p>\n<p>However, the one-month return paints a more optimistic picture, with Pharmaids Pharma surging 12.54%, significantly outpacing the Sensex’s 0.14% rise. This divergence indicates that despite recent minor setbacks, the stock has demonstrated resilience and strong momentum over the last month, potential..."
      },
      {
        "title": "Pharmaids Pharma Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharma-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-outlook-3746457",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PharmaidsPharma_mojoScore_3746457.png",
        "date": "2025-12-04 11:08:19",
        "description": "Pharmaids Pharma has undergone a revision in its market evaluation, reflecting a more cautious analytical perspective driven by recent financial and technical developments. The shift highlights concerns over the company’s operational performance and market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Pharmaids Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-pharmaids-pharma-fallingrising-3708698",
        "imagepath": "",
        "date": "2025-11-17 23:01:35",
        "description": "As of 17-Nov, Pharmaids Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 47.82, which reflects a rise of Rs 3.41 or 7.68%. Today's price summary indicates that the stock opened with a gain of 4.48% and reached an intraday high of Rs 48, marking an 8.08% increase. However, despite this positive movement, the stock has shown a decline of 1.24% over the past week and a significant drop of 32.15% year-to-date. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 66.97% against the 5-day average, which may indicate waning interest despite today's gains.\n\nBroader market context shows that while Pharmaids Pharmaceuticals has outperformed its sector by 7.4% today, it has underperformed the Sensex over the past week and month, which have seen gains of 1.69% and 1.19%, respectively. The stock's long-term performance remains strong, with a 3-ye..."
      },
      {
        "title": "Why is Pharmaids Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-pharmaids-pharma-fallingrising-3702580",
        "imagepath": "",
        "date": "2025-11-14 23:01:57",
        "description": "As of 14-Nov, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 44.13, which reflects a decrease of Rs 1.68 or 3.67%. The stock has underperformed significantly today, with a performance that is 4.04% lower than its sector. It has also touched an intraday low of Rs 43.9, indicating a drop of 4.17%. The stock is trading below all its moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), and there has been a notable decrease in investor participation, with delivery volume falling by 29.48% compared to the 5-day average. Furthermore, the stock is close to its 52-week low, being only 4.83% away from Rs 42. The year-to-date return is down by 37.39%, and the one-year return shows a decline of 41.90%, highlighting a significant downturn in performance.\n\nIn the broader market context, the Sensex has shown a positive return of 1.62% over the past week, contrasting s..."
      },
      {
        "title": "How has been the historical performance of Pharmaids Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-pharmaids-pharma-3694747",
        "imagepath": "",
        "date": "2025-11-12 23:53:35",
        "description": "Answer:\nThe historical performance of Pharmaids Pharma shows a gradual increase in net sales, reaching 19.45 Cr in March 2025, up from 15.11 Cr in March 2024 and starting from 0.00 Cr in March 2023. However, the company has consistently reported negative operating profits, with an operating profit of -12.66 Cr in March 2025, slightly worse than -12.33 Cr in March 2024 and -9.88 Cr in March 2023. The total expenditure has risen to 32.21 Cr in March 2025 from 28.32 Cr in March 2024, contributing to a profit before tax of -17.28 Cr in March 2025, compared to -15.62 Cr in March 2024 and -9.91 Cr in March 2023. The profit after tax also reflects this trend, with losses of -13.51 Cr in March 2025, -11.84 Cr in March 2024, and -7.56 Cr in March 2023. The company's total assets increased to 109.35 Cr in March 2025 from 84.67 Cr in March 2024, while total liabilities also rose to 109.35 Cr from 84.67 Cr, indicating ..."
      },
      {
        "title": "Are Pharmaids Pharma latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-pharmaids-pharma-latest-results-good-or-bad-3693212",
        "imagepath": "",
        "date": "2025-11-12 19:31:25",
        "description": "Pharmaids Pharmaceuticals has reported its financial results for Q2 FY26, revealing a complex situation characterized by significant revenue growth alongside persistent operational challenges. The company achieved net sales of ₹8.61 crores, marking a year-on-year growth of 64.31% and a quarter-on-quarter increase of 29.28%. This represents the highest quarterly revenue in the company's history. However, despite this top-line expansion, Pharmaids continues to face substantial net losses, reporting a consolidated net loss of ₹2.48 crores for the quarter, which reflects a 28.50% deterioration year-on-year.\n\nThe operating margin remains deeply negative at -61.67%, indicating ongoing struggles with cost management and profitability. The company's PAT margin also stands at a negative -29.38%, underscoring the challenges in converting revenue into profit. Notably, employee costs have risen significantly, consuming..."
      },
      {
        "title": "Pharmaids Pharmaceuticals Q2 FY26: Mounting Losses and Deteriorating Margins Signal Deepening Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/pharmaids-pharmaceuticals-q2-fy26-mounting-losses-and-deteriorating-margins-signal-deepening-crisis-3692709",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PharmaidsPharma_quaterlyResult_3692709.png",
        "date": "2025-11-12 09:46:45",
        "description": "Pharmaids Pharmaceuticals Ltd., a Hyderabad-based micro-cap pharmaceutical company, reported a consolidated net loss of ₹2.48 crores in Q2 FY26, marking a deterioration of 28.50% year-on-year from the ₹1.93 crore loss in Q2 FY25. The company's stock has plummeted 44.43% over the past year, currently trading at ₹46.29 with a market capitalisation of ₹162.00 crores, reflecting investor exodus from this loss-making enterprise."
      },
      {
        "title": "When is the next results date for Pharmaids Pharma?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-pharmaids-pharma-3681220",
        "imagepath": "",
        "date": "2025-11-07 23:20:02",
        "description": "The next results date for Pharmaids Pharma is scheduled for 11 November 2025...."
      },
      {
        "title": "Why is Pharmaids Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-pharmaids-pharma-fallingrising-3677067",
        "imagepath": "",
        "date": "2025-11-06 22:50:47",
        "description": "As of 06-Nov, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 46.64, which represents a decrease of Rs 1.57 or 3.26%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 6.38% during this period. Today's trading saw the stock reach an intraday high of Rs 51.91 but ultimately closed at its low. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a rise in delivery volume by 6.9% against the 5-day average, the overall performance today was still below the sector average by 2.49%.\n\nIn the broader market context, Pharmaids Pharmaceuticals has significantly underperformed compared to the benchmark Sensex over various time frames. For instance, in the past week, the stock has declined by 6.92%, while the Sensex has onl..."
      }
    ],
    "total": 89,
    "sid": "799751",
    "stock_news_url": "https://www.marketsmojo.com/news/pharmaids-pharmaceuticals-799751"
  },
  "announcements": [
    {
      "caption": "Re-Lodgment Of Requests For Transfer Of Physical Shares",
      "datetime": "12-Dec-2025",
      "details": "Report on re-lodgment of requests for transfer of Physical shares",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "10-Dec-2025",
      "details": "Enclosed disclosure under Regulation 30 (LODR).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Nov-2025",
      "details": "Newspaper publication of Postal Ballot Notice",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Pharmaids Pharma falling/rising?

2025-12-17 01:07:23

Short-Term Price Dynamics and Market Context

Pharmaids Pharma’s price dipped by 0.04% on 16-Dec, a relatively negligible change in absolute terms but indicative of a cautious market sentiment. Over the past week, the stock has declined by 1.56%, contrasting with the Sensex’s modest gain of 0.02% during the same period. This short-term underperformance suggests some immediate pressures on the stock, possibly linked to reduced investor enthusiasm or profit-taking activities.

However, the one-month return paints a more optimistic picture, with Pharmaids Pharma surging 12.54%, significantly outpacing the Sensex’s 0.14% rise. This divergence indicates that despite recent minor setbacks, the stock has demonstrated resilience and strong momentum over the last month, potential...

Pharmaids Pharma Sees Revision in Market Evaluation Amidst Challenging Fundamentals

2025-12-04 11:08:19

Pharmaids Pharma has undergone a revision in its market evaluation, reflecting a more cautious analytical perspective driven by recent financial and technical developments. The shift highlights concerns over the company’s operational performance and market positioning within the Pharmaceuticals & Biotechnology sector.

Why is Pharmaids Pharma falling/rising?

2025-11-17 23:01:35

As of 17-Nov, Pharmaids Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 47.82, which reflects a rise of Rs 3.41 or 7.68%. Today's price summary indicates that the stock opened with a gain of 4.48% and reached an intraday high of Rs 48, marking an 8.08% increase. However, despite this positive movement, the stock has shown a decline of 1.24% over the past week and a significant drop of 32.15% year-to-date. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 66.97% against the 5-day average, which may indicate waning interest despite today's gains. Broader market context shows that while Pharmaids Pharmaceuticals has outperformed its sector by 7.4% today, it has underperformed the Sensex over the past week and month, which have seen gains of 1.69% and 1.19%, respectively. The stock's long-term performance remains strong, with a 3-ye...

Why is Pharmaids Pharma falling/rising?

2025-11-14 23:01:57

As of 14-Nov, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 44.13, which reflects a decrease of Rs 1.68 or 3.67%. The stock has underperformed significantly today, with a performance that is 4.04% lower than its sector. It has also touched an intraday low of Rs 43.9, indicating a drop of 4.17%. The stock is trading below all its moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), and there has been a notable decrease in investor participation, with delivery volume falling by 29.48% compared to the 5-day average. Furthermore, the stock is close to its 52-week low, being only 4.83% away from Rs 42. The year-to-date return is down by 37.39%, and the one-year return shows a decline of 41.90%, highlighting a significant downturn in performance. In the broader market context, the Sensex has shown a positive return of 1.62% over the past week, contrasting s...

How has been the historical performance of Pharmaids Pharma?

2025-11-12 23:53:35

Answer: The historical performance of Pharmaids Pharma shows a gradual increase in net sales, reaching 19.45 Cr in March 2025, up from 15.11 Cr in March 2024 and starting from 0.00 Cr in March 2023. However, the company has consistently reported negative operating profits, with an operating profit of -12.66 Cr in March 2025, slightly worse than -12.33 Cr in March 2024 and -9.88 Cr in March 2023. The total expenditure has risen to 32.21 Cr in March 2025 from 28.32 Cr in March 2024, contributing to a profit before tax of -17.28 Cr in March 2025, compared to -15.62 Cr in March 2024 and -9.91 Cr in March 2023. The profit after tax also reflects this trend, with losses of -13.51 Cr in March 2025, -11.84 Cr in March 2024, and -7.56 Cr in March 2023. The company's total assets increased to 109.35 Cr in March 2025 from 84.67 Cr in March 2024, while total liabilities also rose to 109.35 Cr from 84.67 Cr, indicating ...

Are Pharmaids Pharma latest results good or bad?

2025-11-12 19:31:25

Pharmaids Pharmaceuticals has reported its financial results for Q2 FY26, revealing a complex situation characterized by significant revenue growth alongside persistent operational challenges. The company achieved net sales of ₹8.61 crores, marking a year-on-year growth of 64.31% and a quarter-on-quarter increase of 29.28%. This represents the highest quarterly revenue in the company's history. However, despite this top-line expansion, Pharmaids continues to face substantial net losses, reporting a consolidated net loss of ₹2.48 crores for the quarter, which reflects a 28.50% deterioration year-on-year. The operating margin remains deeply negative at -61.67%, indicating ongoing struggles with cost management and profitability. The company's PAT margin also stands at a negative -29.38%, underscoring the challenges in converting revenue into profit. Notably, employee costs have risen significantly, consuming...

Pharmaids Pharmaceuticals Q2 FY26: Mounting Losses and Deteriorating Margins Signal Deepening Crisis

2025-11-12 09:46:45

Pharmaids Pharmaceuticals Ltd., a Hyderabad-based micro-cap pharmaceutical company, reported a consolidated net loss of ₹2.48 crores in Q2 FY26, marking a deterioration of 28.50% year-on-year from the ₹1.93 crore loss in Q2 FY25. The company's stock has plummeted 44.43% over the past year, currently trading at ₹46.29 with a market capitalisation of ₹162.00 crores, reflecting investor exodus from this loss-making enterprise.

When is the next results date for Pharmaids Pharma?

2025-11-07 23:20:02

The next results date for Pharmaids Pharma is scheduled for 11 November 2025....

Why is Pharmaids Pharma falling/rising?

2025-11-06 22:50:47

As of 06-Nov, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 46.64, which represents a decrease of Rs 1.57 or 3.26%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 6.38% during this period. Today's trading saw the stock reach an intraday high of Rs 51.91 but ultimately closed at its low. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a rise in delivery volume by 6.9% against the 5-day average, the overall performance today was still below the sector average by 2.49%. In the broader market context, Pharmaids Pharmaceuticals has significantly underperformed compared to the benchmark Sensex over various time frames. For instance, in the past week, the stock has declined by 6.92%, while the Sensex has onl...

View All News